Polymorphism T→C of gene CYP17 promoter and polycystic ovary syndrome risk: A meta-analysis

Gene

Volumn 495, Issue 1, 2012, Pages 16-22

  Li, Ya ^a   Liu, Fei ^b   Luo, Shan ^a   Hu, Han ^a   Li, Xiao Hong ^a   Li, Shang Wei ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

CYP 17; Meta analysis; Polycystic ovary syndrome; Polymorphism

Indexed keywords

CYTOCHROME P450 17;

ARTICLE; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HOMOZYGOTE; HUMAN; META ANALYSIS (TOPIC); OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROMOTER REGION; SYSTEMATIC REVIEW; WILD TYPE;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, BIOLOGICAL; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK; STEROID 17-ALPHA-HYDROXYLASE;

EID: 84862815253     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.12.048     Document Type: Article

References (36)

1. Akhtar M.K., Kelly S.L., Kaderbhai M.A. Cytochrome b(5) modulation of 17α hydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis. J. Endocrinol. 2005, 187:267-274.
2. Apridonidze T., Essah P.A., Iuorno M.J., Nestler J.E. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2005, 90:1929-1935.
3. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
4. Byun E.K., Kim H.J., Oh J.Y., Hong Y.S., Sung Y.A. The prevalence of polycystic ovary syndrome in college students from Seoul. J. Korean Soc. Endocrinol. 2005, 20:120-126.
5. Carey A.H., Chan K.L., Short F., White D., Williamson R., Franks S. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin. Endocrinol. (Oxf) 1993, 38:653-658.
6. Carey A.H., Waterworth D., Patel K., White D., Little J., Novelli P., Franks S., Williamson R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum. Mol. Genet. 1994, 3:1873-1876.
7. Chen Y., Pei J. Factors influencing the association between CYP17 T34C polymorphism and the risk of breast cancer: meta-regression and subgroup analysis. Breast Cancer Res. Treat. 2010, 122:471-481.
8. Cochran W.G. The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
9. Cooper H., Spellacy W., Prem K., Cohen W. Hereditary factors in the Stein-Leventhal syndrome. Am. J. Obstet. Gynecol. 1968, 100:371-387.
10. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
11. Diamanti-Kandarakis E., Bartzis M.I., Zapanti E.D., Spina G.G., Filandra F.A., Tsianateli T.C., Bergiele A.T., Kouli C.R. Polymorphism T->C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertil. Steril. 1999, 71:431-435.
12. Ding, L., 2007. The association between CYP17 gene polymorphism and high blood testosterone level in Shandong women with polycystic ovary syndrome of Han nationality. Available at: (Article in Chinese). http://dlib3.edu.cnki.net/kns50/detail.aspx?dbname=CMFD2007&filename=2007086811.nh.
13. Echiburú B., Pérez-Bravo F., Maliqueo M., Sánchez F., Crisosto N., Sir-Petermann T. Polymorphism T -> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study. Metabolism 2008, 57:1765-1771.
14. Egger M., Davey S.G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
15. Ehrmann D.A. Polycystic ovary syndrome. N. Engl. J. Med. 2005, 352:1223-1236.
16. Ehrmann D.A., Rosenfield R.L., Barnes R.B., Brigell D.F., Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N. Engl. J. Med. 1992, 327:157-162.
17. Ferriman D., Purdie A.W. The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin. Endocrinol. (Oxf) 1979, 11:291-300.
18. Franks S. Polycystic ovary syndrome in adolescents. Int. J. Obes. 2008, 32:1035-1041.
19. Franks S., Gharani N., Waterworth D., Batty S., White D., Williamson R., McCarthy M. The genetic basis of polycystic ovary syndrome. Hum. Reprod. 1997, 12:2641-2648.
20. Franks S., Gharani N., Waterworth D., Batty S., White D., Williamson R., McCarthy M. Genetics of polycystic ovary syndrome. Mol. Cell. Endocrinol. 1998, 145:123-128.
21. Givens J.R. Familial polycystic ovarian disease. Endocrinol. Metab. Clin. North Am. 1988, 17:771-783.
22. Hague W.M., Adams J., Reeders S.T., Peto T.E., Jacobs H.S. Familial polycystic ovaries: a genetic disease. Clin. Endocrinol. (Oxf) 1988, 29:593-605.
23. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta - analyses. BMJ 2003, 327:557-560.
24. Ioannidis J.P., Trikalinos T.A., Ntzani E.E., Contopoulos-Ioannidis D.G. Genetic associations in large versus small studies: An empirical assessment. Lancet 2003, 361:567-571.
25. Kahsar-Miller M., Boots L., Bartolucci A., Azziz R. Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. Fertil. Steril. 2004, 82:973-975.
26. Lunde O., Magnus P., Sandvik L., Hoglo S. Familial clustering in the polycystic ovarian syndrome. Gynecol. Obstet. Invest. 1989, 28:23-30.
27. Luo, S., 2007. Research on Relationship of depressed liver-dispersing and liver fire-purging therapy and polycystic ovary syndrome in Patients with syndrome of liver excessive heat with the polymorphism of CYP11B2/CYP17 gene. Available at: (Article in Chinese). http://dlib3.edu.cnki.net/kns50/detail.aspx?dbname=CDFD2008&filename=2007130930.nh.
28. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
29. Marszalek B., Laciński, Babych N., Capla E., Biernacka-Lukanty J., Warenik-Szymankiewicz A., Trzeciak W.H. Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5'-UTR in patients with polycystic ovarian syndrome. Gynecol. Endocrinol. 2001, 15:123-128.
30. Park J., Lee E., Ramakrishna S., Cha D., Baek K. Association study for single nucleotide polymorphisms in the CYP17A1 gene and polycystic ovary syndrome. Int. J. Mol. Med. 2008, 22:249-254.
31. Pusalkar M., Meherji P., Gokral J., Chinnaraj S., Maitra A. CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome. Fertil. Steril. 2009, 92:653-659.
32. Rosenfield R.L., Barnes R.B., Cara J.F., Lucky A.W. Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil. Steril. 1990, 53:785-791.
33. Sheehan M.T. Polycystic ovarian syndrome: diagnosis and management. Clin. Med. Res. 2004, 2:13-27.
34. Tan L., Zhang L., Gui J.Z. Polymorphism of CYP17 gene in patients with polycystic ovary syndrome of Han nationality in China. J. Zhengzhou Univ. (Med. Sci.) 2005, 40:438-441.
35. Unsal T., Konac E., Yesilkaya E., Yilmaz A., Bideci A., Ilke O.H., Cinaz P., Menevse A. Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome. J. Assist. Reprod. Genet. 2009, 26:205-216.
36. Wang F., Zou Y.F., Feng X.L., Su H., Huang F. CYP17 gene polymorphisms and prostate cancer risk: A meta-analysis based on 38 independent studies. Prostate 2011, 71:1167-1177.